AstraZeneca's revenue from top product Nexium 2006-2023
In 2023, AstraZeneca's Nexium generated 945 million U.S. dollars of revenue. This statistic shows AstraZeneca's revenue from the top product Nexium between 2006 and 2023. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide (based on Rx drug revenue). The multinational company is headquartered in London, UK. AstraZeneca is focused on products for following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. Back in 2008, Nexium revenues amounted to 5.2 billion U.S. dollars.